RT Journal Article
SR Electronic
T1 Indications that Stockholm has reached herd immunity, given limited restrictions, against several variants of SARS-CoV-2
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.07.21260167
DO 10.1101/2021.07.07.21260167
A1 Carlsson, Marcus
A1 Söderberg-Nauclér, Cecilia
YR 2021
UL http://medrxiv.org/content/early/2021/07/13/2021.07.07.21260167.abstract
AB “When COVID-19 cases go up, public compliance with restrictions is poor, when cases go down, public compliance is good.” In this article, we question this explanation and show that relatively low levels of sero-prevalence helps to keep cases down. In other words, the herd-immunity threshold appears to be much lower than previously thought. We construct a mathematical model taking pre-immunity, antibody waning and more infectious variants of concern into consideration, thereby providing a theoretical framework in which the cases in Stockholm county can be fully predicted without relying on neither oscillations in restrictions (and public compliance thereof) nor vaccination roll-out. We also show that it is very difficult to match the data from Stockholm without including pre-immunity, or, which turns out to be equivalent, great variations in susceptibility.Competing Interest StatementCSN has submitted a patent application for discovery of pre-existing immunity of Influenza A possibly important for SARS-CoV-2Funding StatementThis work was supported by the Swedish Medical Research Council (2019-01736).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB was approved by the Swedish Ethical Authority (2020-06333).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll modeling relies on publicly available data from the Swedish Public Health Agency